Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. IOSP
IOSP logo

IOSP Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Innospec Inc (IOSP) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
73.020
1 Day change
-0.23%
52 Week Range
96.380
Analysis Updated At
2026/03/27
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Innospec Inc (IOSP) is not a strong buy at the moment for a beginner investor with a long-term strategy and $50,000-$100,000 to invest. The technical indicators show mixed signals, with bearish moving averages and a high probability of short-term price declines. The financial performance has significantly deteriorated in the latest quarter, with revenue, net income, and EPS all showing sharp declines. Additionally, there are no positive catalysts, no recent news, and no significant trading signals to support a buy decision.

Technical Analysis

The MACD is positive and expanding, indicating bullish momentum. However, the RSI is neutral at 70.138, and the moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading near its resistance level (R1: 72.109), which could act as a ceiling for further price increases. Historical trends suggest a 70% chance of short-term price declines (-2.61% next day, -2.95% next week, -2.72% next month).

Options Data

Bearish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
8
Buy
4

Positive Catalysts

  • NULL identified. No recent news or events to drive positive sentiment.

Neutral/Negative Catalysts

  • The company's financial performance has significantly deteriorated in the latest quarter, with revenue, net income, and EPS all showing sharp declines. Additionally, bearish moving averages and a high probability of short-term price declines are negative indicators.

Financial Performance

In 2025/Q4, revenue dropped by -2.40% YoY to $455.6M, net income dropped by -167.33% YoY to $47.4M, EPS dropped by -167.73% YoY to $1.91, and gross margin dropped by -4.18% YoY to 27.96%. This indicates a significant decline in the company's financial health.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No recent analyst rating or price target changes available.

Wall Street analysts forecast IOSP stock price to rise
1 Analyst Rating
Wall Street analysts forecast IOSP stock price to rise
1 Buy
0 Hold
0 Sell
Moderate Buy
Current: 73.190
sliders
Low
93
Averages
93
High
93
Current: 73.190
sliders
Low
93
Averages
93
High
93
Freedom Capital
initiated
$93
AI Analysis
2025-11-17
Reason
Freedom Capital
Price Target
$93
AI Analysis
2025-11-17
initiated
Reason
Freedom Capital initiated coverage of Innospec with a Buy rating and $93 price target, calling the company an "undervalued" specialty chemicals maker. The firm said it sees potential upside from either new product offerings or opportunistic M&A. Freedom Capital noted that the stock's recent underperformance along with its bottoming earnings "create an attractive risk-reward tradeoff."
Seaport Global
Michael Harrison
Hold
to
Strong Buy
Upgrades
$155
2025-04-21
Reason
Seaport Global
Michael Harrison
Price Target
$155
2025-04-21
Upgrades
Hold
to
Strong Buy
Reason

People Also Watch